SREBF1 and colonic neoplasm: Berberine could also modulate lipogenesis by targeting the SREBP cleavage-activating protein/sterol regulatory element-binding protein-1 (SCAP/SREBP-1) pathway, and then inhibiting colon cancer cell proliferation [86,87].